sp-3164
salarius pharma,spdr s&p biotech,ishares biotechnology
['sp-3164', '$ibb', '$slrx', '$xbi', 'salarius']
$slrx salarius pharmaceuticals unveils promising preclinical data for sp-3164 targeted protein degrader at european hematology association 2023 hybrid congress. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt